5 New Drug Approvals the FDA Gave Top Priority

The U.S. Food and Drug Administration's made it clear that granting a priority review to an application isn't exactly the same thing as making an application's review a top priority.

Over the past five weeks, the agency stamped approvals on five new drugs months ahead of an already shortened schedule.

PDUFA = prescription drug user fee act; SCD = sickle cell disease. Data sources: Company and FDA press releases.

Continue reading

Source Fool.com